Palo Alto Investors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Palo Alto Investors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-29,257	Closed	-$1.27M	–	46
2015 Q3	$1.27M	Sell	29,257 -21,179	-42%	-$1.14M	0.06%	41
2015 Q2	$2.6M	Hold	50,436	–	–	0.12%	37
2015 Q1	$1.98M	Hold	50,436	–	–	0.1%	39
2014 Q4	$1.95M	Buy	50,436 +15,100	+43%	+$576K	0.11%	39
2014 Q3	$1.25M	Buy	35,336 +24,152	+216%	+$709K	0.09%	39
2014 Q2	$302K	Buy	+11,184	New	+$291K	0.02%	42

Other funds holding BSTC

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Palo Alto Investors's BSTC Position: Q4 2015 in Review

Palo Alto Investors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2015, closing a stake of 29,257 shares — an estimated $1.27M sold.

Palo Alto Investors first reported a position in BSTC in Q2 2014 and held it in 6 quarters. The position peaked at $2.6M in Q2 2015. 95 funds tracked by Wall St. Rank hold BSTC as of Q4 2015.

Palo Alto Investors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2015 after selling out during the quarter.
Palo Alto Investors sold 29,257 BioSpecifics Technologies Corp. shares in Q4 2015, an estimated $1.27M.
Palo Alto Investors first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 6 quarters.
Palo Alto Investors's BioSpecifics Technologies Corp. position peaked at $2.6M in Q2 2015.
95 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2015.

Based on Palo Alto Investors's 13F filing for Q4 2015, filed 16 Feb 2016.